American Academy of Ophthalmology Meeting

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Patricio G. Schlottmann, MD, discusses a presentation comparing the 10 main studies on anti-VEGF agents in the treatment of diabetic retinopathy and diabetic macular edema.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Shan Lin, MD, discusses his personal experience using MicroPulse transscleral cyclophotocoagulation (Iridex) to lower IOP in patients with glaucoma.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Ashvin Agarwal, MD, discusses the development of a virtual reality perimeter that allows visual field testing with a lightweight headset. Results can be viewed on a laptop computer, tablet or smartphone.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Theodore Leng, MD, discusses a poster presentation reviewing the treatment of branch retinal vein occlusion and central retinal vein occlusion among the three anti-VEGF agents at 6 months. The study showed similar treatment outcomes for bevacizumab, ranibizumab and aflibercept.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Steven Dell, MD, discusses a study of intense pulsed light therapy on the lower lids and lateral canthal region in patients with meibomian gland dysfunction in dry eye.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Victor Gonzalez, MD, discusses the latest advances and research in tissue-sparing laser treatments for macular disease.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Eva Liang, MD, discusses her study comparing different IOL calculation formulas for accuracy in predicting good visual results when implanting accommodating IOLs.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Richard Adler, MD, discusses the Antares corneal imaging device (Lumenis), which can help identify dry eye disease in asymptomatic patients.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Jeffrey R. Willis, MD, PhD, assistant medical director at Genentech, discusses a large retrospective study using the IRIS Registry to observe patients identified with diabetic macular edema and the treatments most used. The study found most patients were not treated regularly enough over a 1-year interval.

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Priya Narang, MS, discusses how the single-pass four-throw pupilloplasty technique can be effective in cases of Urrets-Zavalia syndrome.